Table 1.
Control Response, ΔF Ratio | Test Response, ΔF Ratio | Inhibition, % | P Value | n | N | |
---|---|---|---|---|---|---|
Puromycin | ||||||
Thapsigargin | 0.313±0.061 | 0.019±0.002 | 93.9 | 0* | 3 | 60 |
Emetine | 0.306±0.014 | 0.119±0.037 | 61.2 | 0.0070* | 3 | 32 |
Anisomycin | 0.226±0.012 | 0.080±0.048 | 64.6 | 0.0079* | 3 | 24 |
Thapsigargin | ||||||
Emetine | 0.341±0.072 | 0.278±0.058 | 18.5 | 0.0012* | 5 | 36 |
Puromycin | 0.274±0.062 | 0.294±0.068 | −7.3 | 0.5829 | 5 | 28 |
Anisomycin (200 μM) | 0.262±0.048 | 0.273±0.032 | −4.2 | 0.4307 | 3 | 24 |
Anisomycin | 0.211±0.086 | 0.197±0.079 | 6.5 | 0.1416 | 3 | 36 |
Anisomycin (37°C) | 0.244±0.017 | 0.249±0.030 | −2.0 | 0.8963 | 5 | 76 |
Anisomycin (1.5 mM Ca2+, 37°C) | 0.183±0.038 | 0.155±0.054 | 15.5 | 0.6823 | 4 | 48 |
Anisomycin (10 mM Ca2+, 37°C) | 0.166±0.040 | 0.150±0.031 | 9.8 | 0.7599 | 4 | 48 |
Ionomycin | ||||||
Emetine | 0.669±0.065 | 0.608±0.065 | 9.2 | 0.0967 | 3 | 18 |
Puromycin | 0.654±0.046 | 0.681±0.046 | −4.1 | 0.7671 | 3 | 18 |
Anisomycin | 1.264±0.289 | 1.148±0.233 | 9.2 | 0.0732 | 3 | 40 |
Anisomycin (37°C) | 0.502±0.087 | 0.383±0.077 | 23.7 | 0.0725 | 4 | 60 |
ATP | ||||||
Emetine | 0.214±0.081 | 0.207±0.060 | 3.3 | 0.7546 | 4 | 64 |
Anisomycin | 0.226±0.077 | 0.235±0.095 | −3.2 | 0.8792 | 3 | 24 |
Puromycin | 0.323±0.028 | 0.253±0.087 | 21.8 | 0.6235 | 3 | 24 |
Endothelin-1 | ||||||
Emetine | 0.504±0.186 | 0.466±0.058 | 7.5 | 0.6530 | 3 | 44 |
Values are means ± SE; n, number of independent experiments; N, number of wells of the 96-well plate. Puromycin, thapsigargin, emetine, ionomycin, ATP, and endothelin-1 were used at 200, 3, 40, 5, 100 and 0.1 μM, respectively. Anisomycin was used at 400 μM unless indicated. Experiments were performed in the absence of extracellular Ca2+ and at room temperature, unless at 37°C as indicated. Preincubation with inhibitors was in the absence of Ca2+ for 1 h unless the preincubation included 1.5 or 10 mM Ca2+ where indicated. ΔF, change in fluorescence.
P < 0.05.